Disease induced
- A5161 ImiquimodTarget: Toll-like receptors (TLRs)Summary: A TLR agonist
- A4457 Streptozotocin1 CitationSummary: Nitrosourea compound; for type 1 diabetes animal models
- A2343 CyclophosphamideSummary: Alkylating chemotherapeutic agent; crosslinks DNA
- B1054 Resiquimod (R-848)2 CitationTarget: Toll-like receptors (TLRs)Summary: Toll-like receptor 7/8 (TLR7/8) dual agonist; for autoimmune disease models
- B1186 Imiquimod hydrochlorideSummary: Toll-like receptor 7 (TLR7) agonist; for psoriasis models
- B8205 Dextran sulfate sodium salt (MW 35000-45000)Summary: Nucleic acid hybridization enhancer; for acute or chronic colitis models
- B7881 D-+-Galactosamine hydrochlorideSummary: For liver injury models and hepatocyte apoptosis studies
- BA9790 RL-6-Me-7-OHSummary: RL-6-Me-7-OH is a semi-antigen that activates human and mouse MAIT cells (=25μM).
- BA9963 O-Phthalimide-C5-acidSummary: 6-N-Phthalimidoyhexanoicacid (compound FH) is a hemi-antigen that contains a carboxyl group at the end of the spacer arm, which is suitable for reacting with the free amine groups of proteins.
- C8213 DigoxigeninSummary: Digoxigenin (DIG) is a steroid.